Medicare Enrolled
Dr. Suelane Do Ouro, MD
Interventional Pain Medicine Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Do Ouro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Do Ouro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Do Ouro
Dr. Suelane Do Ouro is an interventional pain medicine physician in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Do Ouro performed 19,800 Medicare services across 1,939 unique beneficiaries.
Between the years covered by Open Payments, Dr. Do Ouro received a total of $69,638 from 74 pharmaceutical and/or device companies across 1353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Do Ouro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NY
$69,638 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,800
Medicare services
Top 4% in NY for interventional pain medicine physician
1,939
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~990 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,800 | $5 | $7 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,241 | $0 | $0 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
2,368 | $1 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,328 | $100 | $400 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
1,368 | $13 | $83 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
797 | $12 | $197 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
577 | $150 | $450 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
498 | $52 | $604 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
449 | $83 | $1,000 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
155 | $339 | $2,400 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
150 | $155 | $1,500 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
113 | $97 | $769 |
| Electronic analysis and reprogramming of spinal drug pump This procedure involves electronically analyzing and reprogramming a spinal canal drug infusion pump. It does not include the surgical insertion or removal of the device. |
85 | $39 | $525 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $60 | $350 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
69 | $236 | $1,650 |
| New patient office visit, complex (60-74 min) | 69 | $195 | $500 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
67 | $51 | $800 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
56 | $228 | $2,400 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
55 | $37 | $450 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
52 | $92 | $450 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
49 | $115 | $2,000 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
45 | $210 | $2,077 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
44 | $216 | $1,500 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
42 | $386 | $2,000 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
37 | $281 | $362 |
| Skin graft repair of trunk wound, 10 sq cm or less This procedure involves repairing a wound on the trunk by transferring a piece of skin to cover the affected area. The graft covers a surface area of 10.0 square centimeters or less. |
32 | $446 | $3,788 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
29 | $94 | $1,241 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
28 | $128 | $500 |
| Spinal canal tube insertion, revision, or repositioning This procedure involves placing, adjusting, or moving a tube within the spinal canal to deliver medication. |
24 | $243 | $2,600 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
22 | $49 | $573 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
18 | $265 | $2,400 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $134 | $2,000 |
| Cerebrospinal fluid aspiration and shunt injection This procedure involves removing cerebrospinal fluid and injecting medication or fluid into a shunt tube or reservoir. |
17 | $26 | $400 |
| Insertion of programmable spinal drug infusion pump A surgical procedure to implant a programmable pump into the spinal canal for delivering medication. |
15 | $184 | $5,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
76.3% medium
23.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$69,638
Total received (2018-2024)
Avg $9,948/year across 7 years
Top 8% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,049 (58.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,223 (37.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,366 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,997
2023
$8,339
2022
$19,390
2021
$12,345
2020
$8,130
2019
$8,045
2018
$9,392
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,076
Boston Scientific Corporation
$838
Saluda Medical Americas, Inc.
$386
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$384
ABBVIE INC.
$354
Collegium Pharmaceutical, Inc.
$169
Forte Bio-Pharma LLC
$168
Galderma Laboratories, L.P.
$151
MML US, Inc.
$139
SI-BONE, INC.
$97
PFIZER INC.
$72
PROTEGA PHARMACEUTIALS INC
$65
SCILEX PHARMACEUTICALS INC.
$24
Merz Pharmaceuticals, LLC
$23
TerSera Therapeutics LLC
$20
Azurity Pharmaceuticals, Inc.
$19
Abbott Laboratories
$13
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$26,404
Boston Scientific Corporation
$5,614
Flowonix Medical Incorporated
$5,609
Medtronic USA, Inc.
$4,909
BOSTON SCIENTIFIC CORPORATION
$3,905
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,255
Merz North America, Inc.
$2,055
Nevro Corp.
$1,906
Collegium Pharmaceutical, Inc.
$1,429
Horizon Therapeutics plc
$1,422
Amgen Inc.
$1,361
MML US, Inc.
$1,351
Daiichi Sankyo Inc.
$862
PFIZER INC.
$835
ABBVIE INC.
$805
Abbott Laboratories
$799
Supernus Pharmaceuticals, Inc.
$704
Vertiflex, Inc.
$457
Neuronetics, Inc.
$414
TerSera Therapeutics LLC
$397
Saluda Medical Americas, Inc.
$386
Relievant Medsystems, Inc.
$366
Egalet US Inc
$351
Horizon Pharma plc
$347
FIDIA PHARMA USA INC.
$276
Pernix Therapeutics Holdings, Inc.
$272
Assertio Therapeutics, Inc.
$271
Kowa Pharmaceuticals America, Inc.
$245
Galderma Laboratories, L.P.
$243
Scilex Pharmaceuticals Inc.
$206
Kaleo, Inc.
$194
Forte Bio-Pharma LLC
$193
SCILEX PHARMACEUTICALS INC.
$178
Novartis Pharmaceuticals Corporation
$171
DePuy Synthes Sales Inc.
$167
Zyla Life Sciences
$149
AbbVie Inc.
$145
SI-BONE, INC.
$144
Allergan, Inc.
$140
ASSERTIO THERAPEUTICS, Inc.
$135
SPR Therapeutics, Inc
$134
Almatica Pharma LLC
$100
GRT US Holding, Inc.
$92
RedHill Biopharma Inc.
$90
PAINTEQ LLC
$89
Zyla Life Sciences, Inc.
$87
Hikma Pharmaceuticals USA
$68
PROTEGA PHARMACEUTIALS INC
$65
Takeda Pharmaceuticals U.S.A., Inc.
$63
Biohaven Pharmaceutical Holding Company Ltd.
$61
Allergan Inc.
$61
Shionogi Inc
$52
Purdue Pharma L.P.
$48
Biohaven Pharmaceuticals, Inc.
$47
INSYS Therapeutics Inc
$38
BioDelivery Sciences International, Inc.
$38
Jazz Pharmaceuticals Inc.
$38
Amneal Pharmaceuticals LLC
$37
Vertical Pharmaceuticals, LLC
$32
US WorldMeds, LLC
$32
AstraZeneca Pharmaceuticals LP
$25
GE HealthCare
$25
Bioventus LLC
$24
Merz Pharmaceuticals, LLC
$23
Piramal Critical Care
$23
Fidia Pharma USA Inc.
$22
Nalu Medical, Inc.
$22
Vertos Medical, Inc.
$21
Azurity Pharmaceuticals, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
Medline Industries LP
$18
Otsuka America Pharmaceutical, Inc.
$18
IBSA Pharma Inc.
$17
SI-BONE, Inc.
$15
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ACTIVA PC · ACTIVOS 10 BONE CEMENT · ADAPTIVESTIM · AIMOVIG · AJOVY · ARTISAN · ARYMO ER · ASCENDA · AVISTA · AXIUM · Accurian · Aimovig · Amitiza · BOTOX · BUNAVAIL 2.1 mg 30-count box · COMIRNATY · CREON · DRG leads · DUEXIS · DYSPORT · ENTRADA · Entyvio · Evoke · Evzio · FIXATE · FREELINK · Fixate · GABLOFEN · GELSYN 3 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GRALISE · General - Pain Management · Gralise · HORIZANT · HYALGAN · HYMOVIS · HYSINGLA ER · Hymovis · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Kloxxado · LINZESS · LORZONE · LYRICA · LYVISPAH · Licart · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · METRx · MOVANTIK · MYSTIM · MazorX - Renaissance · Morphabond ER · Movantik · NALOCET · NAPRELAN · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · NuDyn · ORTHOVISC · OXTELLAR XR · Omnia · PAINTEQ · PAXLOVID · PEAK · PENNSAID · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · QULIPTA · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · REXULTI · REYVOW · ROXYBOND · ReActiv8 · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SPRIX · SUBSYS · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Seglentis · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · TREXIMET · TROKENDI XR · UBRELVY · UNID_PASS · VANTA ADAPTIVESTIM · VECTRIS · VIBERZI · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xeomin · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for interventional pain medicine physician in NY.
Geographic Context
Interventional pain medicine physicians within 10 mi
89
Per 100K population
5.5
County median income
$104,553
Nearest hospital
MOUNT SINAI WEST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Do Ouro is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Do Ouro experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Do Ouro performed 6,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Do Ouro receive payments from pharmaceutical companies?
Yes. Dr. Do Ouro received a total of $69,638 from 74 companies across 1,353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Do Ouro's costs compare to other interventional pain medicine physicians in New York?
Dr. Do Ouro's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Do Ouro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in New York
Browse interventional pain medicine physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in NY
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in NY
Which NY interventional pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Flowonix Medical Incorporated Payments to Doctors
See all physicians who received payments from Flowonix Medical Incorporated.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology